Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
83 participants
OBSERVATIONAL
2023-01-02
2024-12-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
-Prospective study to screen post stroke patients with sarcopenia and evaluate its effect on recovery
Secondary research purpose:
* To determine the degree of sarcopenia and correlation with poor functional prognosis of stroke in the stroke patient group.
* To determine the degree of sarcopenia and correlation with dixon MRI of thigh muscle
* To evaluate surface EMG (SEMG)-based signals and correlation with sarcopenia
* To determine the degree of sarcopenia and correlation with brain morphometric changes
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combined Exercise and Nutrition Intervention for Spinal Sarcopenia
NCT04810312
Effects of Blood Flow Restriction Training on Muscle Strength and Physical Function for Stroke-Related Sarcopenia
NCT06974461
Sex-specific Determinants of Early-phase Recovery From Skeletal Muscle Disuse
NCT04151901
Multidisciplinary Combined Exercise and Nutrition Intervention for Sarcopenia (2)
NCT07028294
Multidisciplinary Combined Exercise and Nutrition Intervention for Sarcopenia
NCT04948736
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stroke patients with sarcopenia
Group will be stratified according to gender
DEXA Scan
Fu of diagnostic tests
Stroke patients without sarcopenia
Group will be stratified according to gender
DEXA Scan
Fu of diagnostic tests
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DEXA Scan
Fu of diagnostic tests
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with neuromuscular diseases other than stroke that may affect gait function
* Patients unable to conduct clinical trials according to instructions
* Patients with uncontrolled medical/surgical disease
* Patients with metal substances in the body such as cardiac pacemakers, cochlear implants, etc.
* Patients who have difficulty collecting blood
* Patients who are difficult to follow up after 6 months of onset due to moving to another area
* Patients who have Parkinson's disease, dementia, or have a history of neuromuscular diseases such as Guillain-Barré syndrome or myasthenia gravis
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saint Vincent's Hospital, Korea
OTHER
The Catholic University of Korea
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sun Im
MD., PhD.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Catholic University of Korea
Bucheon-si, Gyeonggi-do, , South Korea
St. Vincent's Hospital
Suwon, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VC22ONDI0185
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.